{"preliminary_commentary":{"by_channel":{"youtube":2,"x_thread":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"PLATON","nct_id":"NCT03784755","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=platon-nct03784755. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"PLATON","arms":[{"description":"Standard systemic therapy\n\n\\+ Ablative therapy to untreated prostate primary for patients with low volume metastatic disease burden","label":"Arm 1 (standard of care)","type":"ACTIVE_COMPARATOR"},{"description":"Local Ablative therapy to all sites of disease (including untreated prostate primary)\n\n\\+ Standard systemic therapy","label":"Arm 2 (standard systemic therapy + ablative therapy))","type":"EXPERIMENTAL"}],"collaborators":["Canadian Cancer Society (CCS)"],"completion_date":{"date":"2033-07-30","type":"ESTIMATED"},"conditions":["Prostate Cancer Metastatic"],"enrollment":{"count":409,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Ablative Radiation Therapy","otherNames":["SBRT","Stereotactic External Beam Irradiation","Stereotactic Radiation Therapy","Stereotactic Radiotherapy"],"type":"RADIATION"},{"name":"Standard of care","otherNames":[],"type":"OTHER"}],"last_update":"2026-03-27","lead_sponsor":"Canadian Cancer Trials Group","official_title":"A Randomized Phase III Trial of Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer [PLATON]","overall_status":"ACTIVE_NOT_RECRUITING","phases":["NA"],"primary_completion_date":{"date":"2032-12-31","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Failure-free Survival","timeFrame":"12 years"}],"references":[],"start_date":{"date":"2019-11-15","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer","url":"https://clinicaltrials.gov/study/NCT03784755"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/platon-nct03784755"}